The resolution of the above questions would elucidate a novel mechanism of miR‐103/TRPV3/autophagy in cardiac hypertrophy, and provide a new idea for the therapy of pathological cardiac hypertrophy. This evidence concerns the gene TRPV3 and cardiac hypertrophy.